Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Related Articles by Review for PubMed (Select 1375104)

1.

Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia.

Charache S, Dover GJ, Moore RD, Eckert S, Ballas SK, Koshy M, Milner PF, Orringer EP, Phillips G Jr, Platt OS, et al.

Blood. 1992 May 15;79(10):2555-65.

2.

Determinants of fetal hemoglobin response to hydroxyurea.

Steinberg MH.

Semin Hematol. 1997 Jul;34(3 Suppl 3):8-14. Review.

PMID:
9317196
3.

Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.

Charache S.

Semin Hematol. 1997 Jul;34(3 Suppl 3):15-21. Review.

PMID:
9317197
4.

[Hydroxyurea and other agents stimulating synthesis of fetal hemoglobin].

de Montalembert M.

Pathol Biol (Paris). 1999 Jan;47(1):55-8. Review. French.

PMID:
10081780
5.

Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease.

Dover GJ, Charache S.

Semin Oncol. 1992 Jun;19(3 Suppl 9):61-6. Review.

PMID:
1379374
6.
7.

Pharmacological induction of foetal haemoglobin synthesis in sickle-cell disease.

Saleh AW, Hillen HF.

Neth J Med. 1997 Nov;51(5):169-78. Review.

PMID:
9455096
8.

Hydroxyurea treatment for sickle cell disease.

Steinberg MH.

ScientificWorldJournal. 2002 Jun 25;2:1706-28. Review.

9.
10.

Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease.

Atweh GF, Schechter AN.

Curr Opin Hematol. 2001 Mar;8(2):123-30. Review.

PMID:
11224687
11.

Advances in the use of hydroxyurea.

Ware RE, Aygun B.

Hematology Am Soc Hematol Educ Program. 2009:62-9. doi: 10.1182/asheducation-2009.1.62. Review.

12.

Therapies to increase fetal hemoglobin in sickle cell disease.

Steinberg MH.

Curr Hematol Rep. 2003 Mar;2(2):95-101. Review.

PMID:
12901139
13.

Induction of fetal hemoglobin in the treatment of sickle cell disease.

Fathallah H, Atweh GF.

Hematology Am Soc Hematol Educ Program. 2006:58-62. Review.

14.

Induction of hemoglobin F synthesis in patients with beta thalassemia.

Ley TJ, Nienhuis AW.

Annu Rev Med. 1985;36:485-98. Review.

PMID:
2581500
15.

Hydroxyurea: specific therapy for sickle cell anemia?

Kaufman RE.

Blood. 1992 May 15;79(10):2503-6. Review. No abstract available.

16.

Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.

Stamatoyannopoulos JA, Nienhuis AW.

Annu Rev Med. 1992;43:497-521. Review.

PMID:
1374600
17.
18.

Hydroxyurea and sickle cell disease.

Orringer EP, Parker JC.

Hematol Pathol. 1992;6(4):171-8. Review. No abstract available.

PMID:
1283391
19.

Hereditary persistence of fetal haemoglobin.

Weatherall DJ, Clegg JB.

Br J Haematol. 1975 Feb;29(2):191-8. Review. No abstract available.

PMID:
1103943
20.

Hydroxyurea in sickle cell disease: drug review.

Agrawal RK, Patel RK, Shah V, Nainiwal L, Trivedi B.

Indian J Hematol Blood Transfus. 2014 Jun;30(2):91-6. doi: 10.1007/s12288-013-0261-4. Epub 2013 May 24. Review.

PMID:
24839362
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk